Synthesis and characterization of radioiodinated (S)-5-iodonicotine: A new ligand for potential imaging of brain nicotinic cholinergic receptors by single photon emission computer tomography

Abstract

(S)-5-Iodonicotine (4a), an (S)-nicotine analog iodinated at the 5- position of the pyridine ring, was synthesized and evaluated as a potential radiopharmaceutical for investigating brain nicotine receptors by single photon emission computerized tomography (SPECT). [125I]-(S)-5-Iodonicotine ([125I]-4a) was synthesized by the iododestannylation reaction under no- carrier-added conditions and purified by high-performance liquid chromatography (HPLC). The binding affinity of 4a for brain nicotine receptors was measured in terms of displacement of [3]cytisine from binding sites in rat cortical membranes. The binding data revealed that the affinity of 4a was the same as that of (S)-nicotine and 80-fold higher than that of the (R)-enantiomer (4b). Biodistribution studies in mice disclosed that the brain uptake of [125I]-4a was rapid and profound. Regional cerebral distribution studies in rats by autoradiography disclosed that the accumulation of [125I]-4a was dense in the thalamus, intermediate in the cortex and striatum, and less marked in the cerebellum. Furthermore, the administration of (S)-nicotine reduced the uptake of [125I]-4a in the thalamus and resulted in a nearly identical level of radioactivity in the cerebellum. [125I]-(R)-5-Iodonicotine ([125I]-4b) showed more rapid washout from the brain and a less extensive regional cerebral distribution than the (S)-enantiomer ([125I]-4a]. Thus, 4a bound to brain nicotine receptors in vivo, and therefore iodine-123-labeled 4a may be a potential radioligand for use in in vivo cerebral nicotinic receptor studies by SPECT.